Most phase II trials are also for new untested drugs. They often fail because of adverse events.
PPS is not a new drug. It's repurposed and been in use in humans for many decades.
Given those factors the odds change dramatically in PAR's favour.
- Forums
- ASX - By Stock
- PAR
- Ann: Change of Director's Interest Notice
Ann: Change of Director's Interest Notice, page-12
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
25.0¢ |
Change
0.015(6.38%) |
Mkt cap ! $87.44M |
Open | High | Low | Value | Volume |
24.0¢ | 25.0¢ | 23.0¢ | $95.91K | 396.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 117676 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 36524 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 117676 | 0.240 |
3 | 276969 | 0.235 |
8 | 151921 | 0.230 |
9 | 104772 | 0.225 |
9 | 66558 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 36524 | 4 |
0.255 | 57014 | 4 |
0.260 | 26415 | 3 |
0.270 | 19081 | 2 |
0.275 | 13636 | 2 |
Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |